Defective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de-O-acetylation in N. meningitidis

Abstract

Lytic transglycosylases (LT) are enzymes involved in peptidoglycan (PG) remodeling. However, their contribution to cell wall-modifying complexes and their potential as antimicrobial drug targets remain unclear. Here, we determined a high-resolution structure of the LT, an outer membrane lipoprotein from Neisseria species with a disordered active site helix (alpha helix 30). We show that deletion of the conserved alpha-helix 30 interferes with the integrity of the cell wall, disrupts cell division, cell separation, and impairs the fitness of the human pathogen Neisseria meningitidis during infection. Additionally, deletion of alpha-helix 30 results in hyperacetylated PG, suggesting this LtgA variant affects the function of the PG de-O-acetylase (Ape 1). Our study revealed that Ape 1 requires LtgA for optimal function, demonstrating that LTs can modulate the activity of their protein-binding partner. We show that targeting specific domains in LTs can be lethal, which opens the possibility that LTs are useful drug-targets.

Data availability

Data Availability: Coordinates and structural data have been submitted to the Protein Data Bank under the accession code 6H5F.

The following data sets were generated

Article and author information

Author details

  1. Allison Hillary Williams

    Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur, Paris, France
    For correspondence
    awilliam@pasteur.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0726-141X
  2. Richard Wheeler

    Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Ala-Eddine Deghmane

    Unité des Infection Bactériennes Invasives, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Ignacio Santecchia

    Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Ryan E Schaub

    Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Samia Hicham

    Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Maryse Moya Nilges

    Unité Technologie et Service BioImagerie Ultrastructural, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Christian Malosse

    Unité Technologie et Service Spectrométrie de Masse pour la Biologie, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Julia Chamot-Rooke

    Unité Technologie et Service Spectrométrie de Masse pour la Biologie, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Ahmed Haouz

    Plate-forme de Cristallographie, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Joseph P Dillard

    Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. William P Robins

    Department of Microbiology, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Muhamed-Kheir Taha

    Unité des Infection Bactériennes Invasives, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Ivo Gomperts Boneca

    Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur, Paris, France
    For correspondence
    bonecai@pasteur.fr
    Competing interests
    The authors declare that no competing interests exist.

Funding

European Molecular Biology Organization (ALTF 732-2010)

  • Allison Hillary Williams

European Research Council (PGN from SHAPE to VIR 202283)

  • Ivo Gomperts Boneca

Fondation pour la Recherche Médicale (DBF20160635726)

  • Ivo Gomperts Boneca

Institut Carnot-Pasteur (Maladies Infectious fellowship)

  • Allison Hillary Williams

Institut Carnot Pasteur Microbes and Sante

  • Ignacio Santecchia

Fondation pour la Recherche Médicale (FDT201805005258)

  • Ignacio Santecchia

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal work in this study was carried out at the Institut Pasteur in strict accordance with the European Union Directive 2010/63/EU (and its revision 86/609/EEC) on the protection of animals used for scientific purposes. The laboratory at the Institut Pasteur has the administrative authorization for animal experimentation (Permit Number 75-1554) and the protocol was approved by the Institut Pasteur Review Board that is part of the Regional Committee of Ethics of Animal Experiments of Paris Region (Permit Number: 99-174). All the invasive procedures were performed under anesthesia and all possible efforts were made to minimize animal suffering.

Copyright

© 2020, Williams et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,710
    views
  • 303
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Allison Hillary Williams
  2. Richard Wheeler
  3. Ala-Eddine Deghmane
  4. Ignacio Santecchia
  5. Ryan E Schaub
  6. Samia Hicham
  7. Maryse Moya Nilges
  8. Christian Malosse
  9. Julia Chamot-Rooke
  10. Ahmed Haouz
  11. Joseph P Dillard
  12. William P Robins
  13. Muhamed-Kheir Taha
  14. Ivo Gomperts Boneca
(2020)
Defective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de-O-acetylation in N. meningitidis
eLife 9:e51247.
https://doi.org/10.7554/eLife.51247

Share this article

https://doi.org/10.7554/eLife.51247

Further reading

    1. Microbiology and Infectious Disease
    2. Neuroscience
    Aleksandra Prochera, Anoohya N Muppirala ... Meenakshi Rao
    Research Article

    Glial cells of the enteric nervous system (ENS) interact closely with the intestinal epithelium and secrete signals that influence epithelial cell proliferation and barrier formation in vitro. Whether these interactions are important in vivo, however, is unclear because previous studies reached conflicting conclusions (Prochera and Rao, 2023). To better define the roles of enteric glia in steady state regulation of the intestinal epithelium, we characterized the glia in closest proximity to epithelial cells and found that the majority express the gene Proteolipid protein 1 (PLP1) in both mice and humans. To test their functions using an unbiased approach, we genetically depleted PLP1+ cells in mice and transcriptionally profiled the small and large intestines. Surprisingly, glial loss had minimal effects on transcriptional programs and the few identified changes varied along the gastrointestinal tract. In the ileum, where enteric glia had been considered most essential for epithelial integrity, glial depletion did not drastically alter epithelial gene expression but caused a modest enrichment in signatures of Paneth cells, a secretory cell type important for innate immunity. In the absence of PLP1+ glia, Paneth cell number was intact, but a subset appeared abnormal with irregular and heterogenous cytoplasmic granules, suggesting a secretory deficit. Consistent with this possibility, ileal explants from glial-depleted mice secreted less functional lysozyme than controls with corresponding effects on fecal microbial composition. Collectively, these data suggest that enteric glia do not exert broad effects on the intestinal epithelium but have an essential role in regulating Paneth cell function and gut microbial ecology.

    1. Microbiology and Infectious Disease
    Carley N Gray, Manickam Ashokkumar ... Michael Emerman
    Research Article

    The latent HIV reservoir is a major barrier to HIV cure. Combining latency reversal agents (LRAs) with differing mechanisms of action such as AZD5582, a non-canonical NF-kB activator, and I-BET151, a bromodomain inhibitor is appealing toward inducing HIV-1 reactivation. However, even this LRA combination needs improvement as it is inefficient at activating proviruses in cells of people living with HIV (PLWH). We performed a CRISPR screen in conjunction with AZD5582 & I-BET151 and identified a member of the Integrator complex as a target to improve this LRA combination, specifically Integrator complex subunit 12 (INTS12). Integrator functions as a genome-wide attenuator of transcription that acts on elongation through its RNA cleavage and phosphatase modules. Knockout of INTS12 improved latency reactivation at the transcriptional level and is more specific to the HIV-1 provirus than AZD5582 & I-BET151 treatment alone. We found that INTS12 is present on chromatin at the promoter of HIV and therefore its effect on HIV may be direct. Additionally, we observed more RNAPII in the gene body of HIV only with the combination of INTS12 knockout with AZD5582 & I-BET151, indicating that INTS12 induces a transcriptional elongation block to viral reactivation. Moreover, knockout of INTS12 increased HIV-1 reactivation in CD4 T cells from virally suppressed PLWH ex vivo, and we detected viral RNA in the supernatant from CD4 T cells of all three virally suppressed PLWH tested upon INTS12 knockout, suggesting that INTS12 prevents full-length HIV RNA production in primary T cells. Finally, we found that INTS12 more generally limits the efficacy of a variety of LRAs with different mechanisms of action.